Unitron, Kitchener, Ontario, has announced the next generation of its popular Moxi™ and Quantum™ hearing instruments built on the Era™ platform.  Along with new styles, Moxi2 and Quantum2 create a best first-fit experience for patients, offering evolved natural sound and a full set of features that provide more effortless listening across four technology levels. According to the company, benefits of the new devices include: HR UntronFlexMoxi2ndGen_Family

Exceptional first-fittings. Both product families reportedly incorporate signature technologies that deliver the ease of listening and clarity of speech necessary to create a best first-fit experience and overall increased patient satisfaction. SmartFocus™ 2 includes enhancements that are said to offer a new level of speech intelligibility in noise and limit the distracting noises that impact more than 90% of a patient’s hearing experience. Unitron’s Automatic Adaptation Manager has been shown in a study published in The Hearing Review and a presentation at AudiologyNOW! 2013 to keep new wearers more satisfied by starting them at their preferred listening levels, then transitioning them to the amplification they need, gradually, comfortably, and automatically.

New styles. Moxi2 and Quantum2 product families introduce fresh new styles providing hearing care professionals with even greater flexibility to meet patient needs. The Moxi2 family includes a choice of three receiver-in-canal (RIC) styles, including the Moxi2 Kiss and the new robust Moxi2 Dura, while the Quantum2 family offers a complete selection of performance BTEs and ITEs, including a new BTE.

Increase patient confidence with Flex. Moxi2 and Quantum2 are also available with Unitron Flex:trial™, the industry’s first flexible and risk-free hearing trial solution aimed at improving patient satisfaction and hearing instrument adoption. With Flex:trial, dispensing professionals can fit patients with a same day trial of technology they recommend, at no cost or obligation, allowing them to experience the benefits of hearing instruments in their daily lives. Unitron states that the concept has been highly successful since its introduction to market a year ago, and that Flex:trial is providing an unprecedented ability to meet patient expectations while enhancing business opportunities for clinicians.

“As part of our ongoing commitment to customer success, we are continually working with hearing healthcare providers to understand their needs so that we can ensure we are delivering the products and services that will enhance their business and enable patient success,” says Unitron President Jan Metzdorff.  “This critical customer feedback has helped us raise the bar of excellence with Moxi2 and Quantum2 product families with a focus on creating the best first fit experience possible. Our comprehensive line up of styles provides hearing healthcare providers with more choice to meet patient needs and the latest advancements in natural sound quality offers patients an easy, comfortable listening experience.”

Source: Unitron